Welcome to our dedicated page for Elevra Lithium news (Ticker: ELVR), a resource for investors and traders seeking the latest updates and insights on Elevra Lithium stock.
Elevra Lithium Limited reports news as a North American lithium producer with American Depository Shares traded under ELVR. Recurring updates center on North American Lithium, including spodumene concentrate production, sales, operating costs, safety performance, cash flow, and expansion studies.
Company news also covers quarterly activities reports, project updates for Carolina Lithium, Moblan, Ewoyaa, and Western Australian tenements, offtake and downstream processing discussions, presentation-currency changes, capital actions, and governance matters following the completed Sayona-Piedmont merger.
Elevra Lithium (ELVR) released a Pre-Feasibility Study for a three-stage brownfield expansion of its North American Lithium (NAL) operation in Québec.
The expansion lifts average annual spodumene concentrate production to 373 ktpa (SC5.4, post ramp-up), almost double the 199 ktpa base case and above the prior 338 ktpa scoping estimate, driven in part by higher mill feed grades from ore sorting. Life-of-mine C1 costs decline from C$1,048/t to C$876/t, with post-expansion C1 of C$851/t and AISC of C$918/t. Initial expansion CAPEX totals C$366M (including C$73M contingency) across three stages, and is described as fully funded through Elevra’s May 2026 strategic financing package.
The PFS delivers a post-tax NPV8% of C$3,218M and an expansion-only post-tax NPV8% of C$943M, with a 49.9% post-tax IRR and 34‑month payback. The 20‑year mine life and production target are entirely underpinned by 47.2 Mt of existing Ore Reserves at 1.12% Li₂O.
Elevra Lithium (ASX:ELV, NASDAQ:ELVR) has executed a binding Spodumene Concentrate Supply Agreement with Mangrove Lithium for long-term supply from the North American Lithium (NAL) operation in Québec to Mangrove’s proposed 20,000 tpa LCE conversion facility in Eastern Canada.
The Agreement has an initial 7-year term, extendable by a further seven years unless terminated, and is subject to conditions precedent including Mangrove securing project financing, taking a positive Final Investment Decision by 31 December 2028, and reaching commercial operations at no less than 50% of nameplate capacity within three years thereafter.
Annual contracted volumes are 122,000 dmt in Year 1 and 144,000 dmt from Year 2 on a take-or-pay basis, with options for Mangrove to increase volumes by up to 20% annually and purchase up to 72,000 dmt before commercial operations. Pricing is market-linked with a floor that Elevra expects to be above NAL’s cost of production and no price ceiling, and domestic deliveries are expected to avoid ocean freight costs. Both companies have separate backing from the Canada Growth Fund.
Elevra Lithium (ASX:ELV, NASDAQ:ELVR) plans to release its FY26 Full Year Report on Friday, 28 August 2026. The company will hold an investor webcast on the same day at 9:30am AEST (Thursday, 27 August 2026, 7:30pm EDT) with live and archived online access.
Elevra Lithium (ASX:ELV, NASDAQ:ELVR) has completed the sale of all its rights, interests and obligations over exploration licence E45/2364 in Western Australia to Wildcat Resources. Wildcat assumes full ownership, control and liability for the tenement.
According to Elevra, consideration totals A$16 million plus an ongoing royalty, comprising A$5 million cash on completion, A$8 million in Wildcat shares at A$0.353 per share, and a deferred A$3 million cash payment following Wildcat’s completed feasibility study. Elevra is also entitled to contingent cash of A$0.70 per tonne for each tonne of JORC Pegmatite Mineral Resource defined on E45/2364. The company states the deal monetises a non-core asset, simplifies its portfolio, and supports capital allocation to its core North American lithium growth projects.
Elevra Lithium (ASX: ELV, NASDAQ: ELVR) reported Q4 FY26 records at North American Lithium (NAL), with spodumene concentrate production up 15% QoQ to 54,479 dmt at 5.0% grade and lithium recovery improving to 71% (+5 percentage points QoQ). Mill utilisation remained high at 92% despite a major planned shutdown, and safety performance recorded no lost-time injuries.
Spodumene sales fell 39% QoQ to 33,977 dmt, with revenue down 61% to US$31 million as all tonnes were delivered under a legacy, lagged-pricing contract at an average US$921/dmt, 37% below the prior quarter. This contract has now been finalised. Unit operating costs per tonne sold increased 3% QoQ to US$907/dmt.
According to Elevra, an Updated Scoping Study for the NAL Brownfield Expansion more than doubled incremental post-tax NPV8% to C$969 million while maintaining total capex at C$366 million. A Strategic Financing Package was announced, including a US$196 million institutional placement, US$102 million in Canada Growth Fund convertible notes (two tranches) and an US$11 million share purchase plan, intended to fully fund the NAL Expansion.
Elevra also agreed to sell its interest in the Ewoyaa Project in Ghana to Huayou for approximately US$71 million cash (before fees) and purchased additional Moblan offtake rights to control 100% of its 60% pro rata entitlement. Group cash at 30 June 2026 was US$255 million, with net cash of US$200 million and a prepayment facility of US$55 million (since reduced by US$9 million in July 2026).
Elevra Lithium (ASX:ELV, NASDAQ:ELVR) plans to release its June 2026 Quarterly Activities Report on Tuesday, 28 July 2026 (AEST). The company will host an investor webcast on the same day at 9:30am AEST (7:30pm EDT on Monday, 27 July 2026), accessible via an online registration link and the Elevra website, with an archived replay available about two hours after completion.
Elevra Lithium (NASDAQ:ELVR, ASX:ELV) has broken ground on its fully funded North American Lithium (NAL) Expansion project, following a May 2026 capital raise that strengthened its balance sheet.
Stage 1 completion is targeted for mid-CY27, with an expected 15–20% increase in annual spodumene concentrate capacity and lower unit operating costs.
Elevra Lithium (ASX:ELV, NASDAQ:ELVR) has purchased and terminated Waratah’s Moblan spodumene offtake rights. Moblan is 60% owned by Elevra and 40% by Investissement Québec.
Elevra will issue Waratah US$5m in shares and US$0.5m in options, regaining 100% of its attributable Moblan offtake and removing a life-of-mine 5% price discount.
Elevra Lithium (ASX:ELV, NASDAQ:ELVR) released an updated Scoping Study for expanding the North American Lithium mine, outlining a three-stage, staged growth plan.
The study lifts incremental post-tax NPV(8%) to C$969M, total project NPV(8%) to C$3,112M, targets 338 ktpa concentrate, maintains total CAPEX at US$270M, and projects a 42% post-tax IRR with 25‑month payback.
Elevra Lithium (NASDAQ:ELVR, ASX:ELV) agreed to sell its entire interest, including offtake rights, in the Ewoyaa Lithium Project in Ghana to Zhejiang Huayou Cobalt for approximately US$71 million in cash before fees and taxes.
Completion is subject to Ghanaian regulatory approvals and is expected by the end of Q1 FY27, enabling Elevra to focus on core North American assets, simplify its portfolio, and remove ongoing Ewoyaa funding obligations.